1M6MYTD1A5AMAX
Caricamento quotazioni...
Previsioni
| Acquista |
1 |
| Mantieni |
0 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
Supply stoppages weigh on Olympus: 2026 sales forecast cut 2% on a constant-currency basis
For Q3 of fiscal 2026 Olympus reported sales of 2,610 Oku Yen (+4% on a constant-currency basis) and adjusted operating profit of 393 Oku Yen (margin 15.1%). Due to supply stoppages of about 90 Oku Yen caused by FDA inspections, the company lowered its sales forecast excluding currency effects by 2% but kept its operating margin targets unchanged (now 12.7–13.9%). CEO Bob White announced measures to remedy the supply issues, strengthen quality and regulatory teams, and implement strategic initiatives to improve margins and growth; the stock fell 5.22% after the announcement. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 1,31Mld | 7,94% |
| Utile lordo | 856,00M | 7,62% |
| Utile netto | 104,26M | 97,01% |
| EBITDA | 268,02M | 56,17% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 12,17Mld€ |
Numero di azioni | 1,06Mld |
Massimo/minimo a 52 settimane | 11,79€ - 6,94€ |
| Dividendi | No |
Beta | 0,21 |
Rapporto P/E | 30,88 |
Rapporto PEG | −1,11 |
Rapporto P/B | 3,16 |
Rapporto P/S | 2,32 |
Profilo aziendale
| Nome | OLYMPUS CORP. ADR |
| CEO | Robert White |
| Dipendenti | 28.138 |
Scopri gli asset
Gli azionisti di OLYMPUS CORP. ADR investono anche nei seguenti asset
